Anti-obesity effect of berberine in mice fed a high fat diet

Journal of Food Science and Nutrition

Volumn 14, Issue 4, 2009, Pages 298-302

  Hwang, Kwang Hyun ^a   Ahn, Ji Yun ^b   Kim, Suna ^b   Ha, Tae Youl ^b  

^a University of Science and Technology (UST)   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

Adipose tissue; Anti obesity; Berberine; C EBP

Indexed keywords

MUS;

EID: 84866539788     PISSN: 1226332X     EISSN: None     Source Type: Journal    
DOI: 10.3746/jfn.2009.14.4.298     Document Type: Article

References (22)

1. Guilbert JJ. 2002. The World Health Report 2002? Reducing risks, promoting healthy life. Education for Health 16: 1-230.
2. Kim DM, Ahn CW, Nam SY. 2005. Prevalence of obesity in Korea. Obes Rev 6: 117-121.
3. Pi-Sunyer FX, Becker DM, Bouchard C. 1998. NHLBI obesity education initiative expert panel on the identification, evaluation, and treatment of overweight and obesity in adults. Obes Res 6: 51S-209S.
4. Waldron A. 2007. Obesity and obesity-related complications screening of adults and children in the primary care office. Northeast Florida Medicine 58: 21-24.
5. Saltiel AR, Kahn CR. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806.
6. Grundy SM. 2004. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89: 2595-2600.
7. Tilg H, Moschen AR. 2006. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783.
8. Anghel SI, Wahli W. 2007. Fat poetry: a kingdom for PPAR gamma. Cell Res 17: 486-511.
9. Cooke D, Bloom S. 2006. The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov 5: 919-931.
10. Ikram M. 1975. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med 28: 353-358.
11. Subbaiah TV, Amin AH. 1967. Effect of berberine sulphate on Entamoeba histolytica. Nature 215: 527-528.
12. Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P, You XF, Li ZR, Si SY, Zhao LX, Pan HN, Jiang JD. 2009. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 58: 109-119.
13. Huang C, Zhang YB, Gong ZW, Sheng XY, Li ZM, Zhang W, Qin Y. 2006. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPAR gamma pathway. BBRC 348: 571-578.
14. Choi BH, Ahn IS, Kim YH, Park JW, Lee SY, Hyun CK, Do MS. 2006. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp Mol Med 38: 599-605.
15. Cho IJ, Ahn JY, Kim S, Choi MS, Ha TY. 2008. Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters. BBRC 367: 190-194.
16. Zhou JY, Zhou SW, Zhang KB, Tang JL, Guang LX, Ying Y, Xu Y, Zhang L, Li DD. 2008. Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biol Pharm Bull 31: 1169-1176.
17. Unger RH. 2003. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 14: 398-402.
18. Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. 2009. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 126: 5-17.
19. Yin J, Gao Z, Liu D, Liu Z, Ye J. 2008. Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab 294: E148-E156.
20. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274: 19055-19062.
21. Ramji DP, Foka P. 2002. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575.
22. Olofsson LE, Melander MO, William-Olsson L, Sjöström KSL, Groop L, Carlsson B, Carlsson LMS, Olsson B. 2008. CCAAT/enhancer binding protein (C/EBP) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C/EBP is associated with serum levels of triglycerides. J Clin Endocrinol Metab 93: 4880-4886.